ibuprofen 200 mg and diphenhydramine citrate 38 mg
Generic: ibuprofen, diphenhydramine citrate
Labeler: pld acquisitions llc dba avma pharma solutionsDrug Facts
Product Profile
Brand Name
ibuprofen 200 mg and diphenhydramine citrate 38 mg
Generic Name
ibuprofen, diphenhydramine citrate
Labeler
pld acquisitions llc dba avma pharma solutions
Dosage Form
TABLET
Routes
Active Ingredients
diphenhydramine citrate 38 mg/1, ibuprofen 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63548-0197
Product ID
63548-0197_fbc47d79-348d-436e-ae3f-364d76f58e49
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA211404
Listing Expiration
2026-12-31
Marketing Start
2024-04-11
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
635480197
Hyphenated Format
63548-0197
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ibuprofen 200 mg and diphenhydramine citrate 38 mg (source: ndc)
Generic Name
ibuprofen, diphenhydramine citrate (source: ndc)
Application Number
ANDA211404 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 38 mg/1
- 200 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 BOX (63548-0197-2) / 20 TABLET in 1 BOTTLE, PLASTIC
- 300 TABLET in 1 BOTTLE, PLASTIC (63548-0197-3)
- 8 TABLET in 1 BOTTLE, PLASTIC (63548-0197-8)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "fbc47d79-348d-436e-ae3f-364d76f58e49", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0000000000000"], "unii": ["4OD433S209", "WK2XYI10QM"], "rxcui": ["895664"], "spl_set_id": ["a7d729bf-6d7a-415a-a414-cae0ba6d0063"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["PLD Acquisitions LLC DBA Avma Pharma Solutions"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (63548-0197-2) / 20 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "63548-0197-2", "marketing_start_date": "20240411"}, {"sample": false, "description": "300 TABLET in 1 BOTTLE, PLASTIC (63548-0197-3)", "package_ndc": "63548-0197-3", "marketing_start_date": "20240411"}, {"sample": false, "description": "8 TABLET in 1 BOTTLE, PLASTIC (63548-0197-8)", "package_ndc": "63548-0197-8", "marketing_start_date": "20240411"}], "brand_name": "Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg", "product_id": "63548-0197_fbc47d79-348d-436e-ae3f-364d76f58e49", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "63548-0197", "generic_name": "Ibuprofen, Diphenhydramine Citrate", "labeler_name": "PLD Acquisitions LLC DBA Avma Pharma Solutions", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Ibuprofen 200 mg and Diphenhydramine Citrate 38 mg", "active_ingredients": [{"name": "DIPHENHYDRAMINE CITRATE", "strength": "38 mg/1"}, {"name": "IBUPROFEN", "strength": "200 mg/1"}], "application_number": "ANDA211404", "marketing_category": "ANDA", "marketing_start_date": "20240411", "listing_expiration_date": "20261231"}